Clinical Trial Update: Pharmacogenetic Dosage Algorithm for Acenocoumarol

View source ↗

Summary

A completed clinical trial evaluating a pharmacogenetic dosing algorithm for acenocoumarol intended to tailor anticoagulation dosing. Conditions included atrial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Valvular Heart Disease
• Venous Thromboembolism

Drugs mentioned

• Acenocoumarol (Acenocoumarol)

Snippet

Sponsor: Instituto de Investigación Hospital Universitario La Paz | Conditions: Atrial Fibrillation, Venous Thromboses | Status: COMPLETED